Research and Clinical Trials

Clinical trials are studies designed to find new and better ways to treat patients with neuropathy. The physicians at the Maryland Peripheral Neuropathy Center are currently conducting the clinical trials listed below.

For more information on our studies, please call Ms. Denise Landrum at 410-328-3100 or e-mail her at CLandrum@som.umaryland.edu.

  • A Randomized, Double-Blind, Placebo Controlled Cross-Over Study of the Effectiveness of Immune Globulin Intravenous (human), 10% (IGIV, 10%) for the Treatment of Multifocal Motor Neuropathy
  • Improving Neuropathy and Mobility in Early Diabetes (Inmed) Study
  • Long Term Effects of Diet and Exercise on Early Diabetic Neuropathy (INMEDEX)
  • Improving Autonomic Function and Balance in Diabetic Neuropathy (IMABIN STUDY)
    • Investigators at the VA Maryland Health Care System and University of Maryland (Drs. James Russell and Lindsay Zilliox) are conducting a study for patients with type II diabetes or prediabetes who also have neuropathy (damage to nerves in their legs or the nerves that control heart function or blood pressure). In the Improving Autonomic Function and Balance in Diabetic Neuropathy (IMABIN Study), participants could have problems with their nerves and/or problems with their balance.  We are recruiting participants for a 1-year trial to compare two lifestyle interventions and to determine if the interventions improve neuropathy and balance.  A preliminary study has suggested that a lifestyle intervention may help patients with mild nerve disease.  Participants will be randomized into one of two groups (put into one of the two groups by the flip of a coin).  Both groups will receive an intervention to improve their lifestyle but the interventions will be different in the two groups.  The interventions focus on improving mobility, balance and nutrition.  The Participants will come to Baltimore City for part of their care. Patients will be reimbursed for the study. Some meals will be provided.  Patients will receive free testing, and nutrition and exercise counseling on nutrition, exercise, and balance as part of this trial.

      If you are interested in participating in the study and can answer yes to all the inclusion criteria below, you may be eligible for inclusion in the study. Please contact Ms. Rizamarie Empeño at 410-328-6583 or INMED@som.umaryland.edu.


      Essential Screening Criteria

      Y N  
      Age 30-80 years
      Prediabetes or early controlled diabetes
      Otherwise medically stable
      Have no cause for neuropathy other than prediabetes or diabetes
      Willing to accept assignment to either intervention group

For more information and/or to make an appointment with the Maryland Peripheral Neuropathy Center, please call 410-328-3100.

This page was last updated: March 19, 2014

         
Average rating (1)